company background image
EEVIA logo

Eevia Health Oyj NGM:EEVIA Stock Report

Last Price

SEK 0.17

Market Cap

SEK 11.2m

7D

0.9%

1Y

-84.2%

Updated

22 Dec, 2024

Data

Company Financials

My Notes

Capture your thoughts, links and company narrative

Eevia Health Oyj Competitors

Price History & Performance

Summary of share price highs, lows and changes for Eevia Health Oyj
Historical stock prices
Current Share PriceSEK 0.17
52 Week HighSEK 1.80
52 Week LowSEK 0.13
Beta1.13
1 Month Change-25.34%
3 Month Change-56.75%
1 Year Change-84.22%
3 Year Change-98.09%
5 Year Changen/a
Change since IPO-97.62%

Recent News & Updates

Recent updates

Shareholder Returns

EEVIASE PharmaceuticalsSE Market
7D0.9%0.4%-2.7%
1Y-84.2%-2.4%4.6%

Return vs Industry: EEVIA underperformed the Swedish Pharmaceuticals industry which returned -2.4% over the past year.

Return vs Market: EEVIA underperformed the Swedish Market which returned 4.6% over the past year.

Price Volatility

Is EEVIA's price volatile compared to industry and market?
EEVIA volatility
EEVIA Average Weekly Movement32.1%
Pharmaceuticals Industry Average Movement9.0%
Market Average Movement5.6%
10% most volatile stocks in SE Market11.3%
10% least volatile stocks in SE Market3.2%

Stable Share Price: EEVIA's share price has been volatile over the past 3 months compared to the Swedish market.

Volatility Over Time: EEVIA's weekly volatility has increased from 24% to 32% over the past year.

About the Company

FoundedEmployeesCEOWebsite
201721Stein Ulveeeviahealth.com

Eevia Health Oyj produces and distributes organic bioactive plant extracts in Finland and internationally. The company offers bilberry, lingonberry, chaga-mushroom, pine bark, elderberry, and tart cherry extracts. Its products are used in dietary supplements and food products.

Eevia Health Oyj Fundamentals Summary

How do Eevia Health Oyj's earnings and revenue compare to its market cap?
EEVIA fundamental statistics
Market capSEK 11.16m
Earnings (TTM)-SEK 33.09m
Revenue (TTM)SEK 16.46m

0.7x

P/S Ratio

-0.3x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
EEVIA income statement (TTM)
Revenue€1.43m
Cost of Revenue€194.35k
Gross Profit€1.24m
Other Expenses€4.11m
Earnings-€2.88m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.043
Gross Margin86.42%
Net Profit Margin-201.00%
Debt/Equity Ratio22.2%

How did EEVIA perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 17:12
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Eevia Health Oyj is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution